Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luscombe

Showing results (661-670 of 713) with videos related to

Pageof 72
Sort By:
ACS Medicinal Chemistry Letters|September 28, 2018
VU6007477, a Novel M<sub>1</sub> PAM Based on a Pyrrolo[2,3-<i>b</i>]pyridine Carboxamide Core Devoid of Cholinergic Adverse EventsJulie L Engers, Elizabeth S Childress, Madeline F Long, et al.
Journal of Medicinal Chemistry|January 5, 2019
Discovery of an Orally Bioavailable and Central Nervous System (CNS) Penetrant mGlu<sub>7</sub> Negative Allosteric Modulator (NAM) in Vivo Tool Compound: N-(2-(1 H-1,2,4-triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide (VU6012962)Carson W Reed, Samantha E Yohn, Jordan P Washecheck, et al.
Genes & Development|March 5, 2015
Control of a neuronal morphology program by an RNA-binding zinc finger protein, UnkemptJernej Murn, Kathi Zarnack, Yawei J Yang, et al.
Nature Structural & Molecular Biology|May 17, 2016
Functional interplay between MSL1 and CDK7 controls RNA polymerase II Ser5 phosphorylationSarantis Chlamydas, Herbert Holz, Maria Samata, et al.
Journal of Medicinal Chemistry|October 24, 2018
Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu<sub>2</sub>) Negative Allosteric Modulators (NAMs) Based on Functionalized Pyrazolo[1,5- a]pyrimidine-5-carboxamide and Thieno[3,2- b]pyridine-5-carboxamide CoresElizabeth S Childress, Joshua M Wieting, Andrew S Felts, et al.
Journal of Medical Genetics|September 17, 2009
Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorderBridget A Fernandez, Wendy Roberts, Brian Chung, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2019
Discovery of a novel 3,4-dimethylcinnoline carboxamide M<sub>4</sub> positive allosteric modulator (PAM) chemotype via scaffold hoppingKayla J Temple, Julie L Engers, Madeline F Long, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Discovery of VU6008677: A Structurally Distinct Tricyclic M<sub>4</sub> Positive Allosteric Modulator with Improved CYP450 ProfileRory A Capstick, Sean R Bollinger, Julie L Engers, et al.
Development, Growth & Differentiation|July 18, 2020
A genome database for a Japanese population of the larvacean Oikopleura dioicaKai Wang, Ryo Tomura, Wei Chen, et al.
Cell|January 22, 2013
DNA-binding specificities of human transcription factorsArttu Jolma, Jian Yan, Thomas Whitington, et al.
Pageof 72

Showing results (661-670 of 713) with videos related to

Sort By:
Pageof 72
ACS Medicinal Chemistry Letters|September 28, 2018
VU6007477, a Novel M<sub>1</sub> PAM Based on a Pyrrolo[2,3-<i>b</i>]pyridine Carboxamide Core Devoid of Cholinergic Adverse EventsJulie L Engers, Elizabeth S Childress, Madeline F Long, et al.
Journal of Medicinal Chemistry|January 5, 2019
Discovery of an Orally Bioavailable and Central Nervous System (CNS) Penetrant mGlu<sub>7</sub> Negative Allosteric Modulator (NAM) in Vivo Tool Compound: N-(2-(1 H-1,2,4-triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide (VU6012962)Carson W Reed, Samantha E Yohn, Jordan P Washecheck, et al.
Genes & Development|March 5, 2015
Control of a neuronal morphology program by an RNA-binding zinc finger protein, UnkemptJernej Murn, Kathi Zarnack, Yawei J Yang, et al.
Nature Structural & Molecular Biology|May 17, 2016
Functional interplay between MSL1 and CDK7 controls RNA polymerase II Ser5 phosphorylationSarantis Chlamydas, Herbert Holz, Maria Samata, et al.
Journal of Medicinal Chemistry|October 24, 2018
Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu<sub>2</sub>) Negative Allosteric Modulators (NAMs) Based on Functionalized Pyrazolo[1,5- a]pyrimidine-5-carboxamide and Thieno[3,2- b]pyridine-5-carboxamide CoresElizabeth S Childress, Joshua M Wieting, Andrew S Felts, et al.
Journal of Medical Genetics|September 17, 2009
Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorderBridget A Fernandez, Wendy Roberts, Brian Chung, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2019
Discovery of a novel 3,4-dimethylcinnoline carboxamide M<sub>4</sub> positive allosteric modulator (PAM) chemotype via scaffold hoppingKayla J Temple, Julie L Engers, Madeline F Long, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Discovery of VU6008677: A Structurally Distinct Tricyclic M<sub>4</sub> Positive Allosteric Modulator with Improved CYP450 ProfileRory A Capstick, Sean R Bollinger, Julie L Engers, et al.
Development, Growth & Differentiation|July 18, 2020
A genome database for a Japanese population of the larvacean Oikopleura dioicaKai Wang, Ryo Tomura, Wei Chen, et al.
Cell|January 22, 2013
DNA-binding specificities of human transcription factorsArttu Jolma, Jian Yan, Thomas Whitington, et al.
Pageof 72